[ Tips ] 一分鐘使用導覽
商品編號： 9-808-005 出版日期： 2007/10/15 作者姓名： Higgins, Robert F.;Kazan, Brent 商品類別： Finance 商品規格： 27p 再版日期： 2013/07/03 地域： 產業： Pharmaceutical industry 個案年度： -
商品敘述：
In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora Biosciences. The combination of Vertex''s and Aurora''s technologies would improve the flow of novel drug candidates into development. However, several questions related to the integration of Aurora into Vertex were still unresolved, the most pressing being Aurora''s major collaboration with the Cystic Fibrosis Foundation (CFF). Were venture philanthropy and foundation deals an appropriate funding mechanism for a public company like Vertex? How could the board of Vertex and the CFF fundamentally align the objectives of a for-profit company with those of a non-profit institution? Those were the questions faced by the Vertex executives.
涵蓋領域：
Mergers and acquisitions;Nonprofit organizations;Philanthropy;Long term financing;Strategic alignment;Corporate governance;Business goals;Risk analysis
相關資料：
Case Teaching Plan, (9-813-021), 7p, by Robert F. Higgins
哪些人也有訂購？